Katelyn W. Sylvester

Papers

Total Citations

H-Index

About

Katelyn W. Sylvester is a leading researcher in the field of pharmacy automation and oncology safety, with a primary focus on the operational and economic impacts of robotic antineoplastic preparation. Her most cited work, a 2012 study with 73 citations, systematically evaluated how robotic compounding of hazardous antineoplastic drugs can enhance safety for healthcare workers, streamline pharmacy workflow, and reduce overall costs. This seminal contribution provided critical evidence that automation not only minimizes human exposure to toxic agents but also improves preparation accuracy and efficiency, addressing a longstanding challenge in hospital pharmacies. Sylvester’s research has been instrumental in guiding the adoption of robotic systems in clinical settings, influencing both policy and practice in sterile compounding. Her work is widely recognized for bridging the gap between technological innovation and practical healthcare delivery, making her a key voice in discussions on pharmacy safety and operational optimization. Through rigorous cost-benefit analyses and workflow studies, she has demonstrated that automation is a viable, scalable solution for high-risk medication preparation, cementing her impact on modern pharmacy practice.